Nalaganje...

A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling

The inhibition of β-catenin/LEF-1 signaling is an emerging strategy in cancer therapy. However, clinical targeted treatment of the β-catenin/LEF-1 complex remains relatively ineffective. Therefore, development of specific molecular targets is a key approach for identifying new cancer therapeutics. T...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Hsieh, Tsung-Hua, Hsu, Chia-Yi, Tsai, Cheng-Fang, Chiu, Chien-Chih, Liang, Shih-Shin, Wang, Tsu-Nai, Kuo, Po-Lin, Long, Cheng-Yu, Tsai, Eing-Mei
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707489/
https://ncbi.nlm.nih.gov/pubmed/26750754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep19156
Oznake: Označite
Brez oznak, prvi označite!